Jamieson is delighted to announce that it has advised Emma Rooth (CEO) and the management team of Torbay Pharmaceuticals on the sale of the business to NorthEdge.
Established in the 1970s as part of the Torbay and Devon NHS Foundation, Torbay Pharmaceuticals is a sterile injectable contract manufacturer and licence holder with over 250 employees supporting both national and international clients within the healthcare and pharma industries. The acquisition by NorthEdge will support its next phase of international growth.
David Kirkpatrick and Alison Dunning advised the management team on the transaction and new incentive plan arrangements.
